Elosulfase Alfa: a review of its use in patients with mucopolysaccharidosis type IVA (Morquio A syndrome).
about
The Use of Gene Ontology Term and KEGG Pathway Enrichment for Analysis of Drug Half-LifeCardiovascular Abnormalities in Egyptian Children with Mucopolysaccharidoses.Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives.Measurement of Elevated Concentrations of Urine Keratan Sulfate by UPLC-MSMS in Lysosomal Storage Disorders (LSDs): Comparison of Urine Keratan Sulfate Levels in MPS IVA Versus Other LSDs.
P2860
Elosulfase Alfa: a review of its use in patients with mucopolysaccharidosis type IVA (Morquio A syndrome).
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Elosulfase Alfa: a review of i ...... type IVA (Morquio A syndrome).
@en
type
label
Elosulfase Alfa: a review of i ...... type IVA (Morquio A syndrome).
@en
prefLabel
Elosulfase Alfa: a review of i ...... type IVA (Morquio A syndrome).
@en
P2860
P1433
P1476
Elosulfase Alfa: a review of i ...... type IVA (Morquio A syndrome).
@en
P2860
P2888
P304
P356
10.1007/S40259-014-0108-Z
P577
2014-10-01T00:00:00Z